These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34051709)

  • 41. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.
    Sathekge MM; Maes A; Pottel H; Stoltz A; van de Wiele C
    S Afr Med J; 2010 Sep; 100(9):598-601. PubMed ID: 20822650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
    Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.
    Sim YT; Goh YG; Dempsey MF; Han S; Poon FW
    Lung; 2013 Dec; 191(6):625-32. PubMed ID: 24013495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
    Dabrowska M; Krenke R; Korczynski P; Maskey-Warzechowska M; Zukowska M; Kunikowska J; Orłowski T; Chazan R
    Medicine (Baltimore); 2015 Apr; 94(15):e666. PubMed ID: 25881842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
    Lin KH; Lee RC; Liu RS; Chang CY
    Nucl Med Commun; 2016 Apr; 37(4):356-62. PubMed ID: 26796032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First pass dual input volume CT-perfusion of lung lesions: The influence of the CT- value range settings on the perfusion values of benign and malignant entities.
    Bohlsen D; Talakic E; Fritz GA; Quehenberger F; Tillich M; Schoellnast H
    Eur J Radiol; 2016 Jun; 85(6):1109-14. PubMed ID: 27161059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography of incidentally detected small pulmonary nodules.
    Fischer BM; Mortensen J; Dirksen A; Eigtved A; Højgaard L
    Nucl Med Commun; 2004 Jan; 25(1):3-9. PubMed ID: 15061259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
    Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
    BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy.
    Calcagni ML; Taralli S; Cardillo G; Graziano P; Ialongo P; Mattoli MV; Di Franco D; Caldarella C; Carleo F; Indovina L; Giordano A
    Ann Thorac Surg; 2016 Apr; 101(4):1303-9. PubMed ID: 26822348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.
    Alkhawaldeh K; Bural G; Kumar R; Alavi A
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):246-52. PubMed ID: 17938921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
    Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
    Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
    Şahin E; Kara A; Elboğa U
    Radiol Med; 2016 Dec; 121(12):944-949. PubMed ID: 27567614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
    Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
    Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fluorine-18 fluorodeoxyglucose uptake in patients with benign pulmonary nodules].
    Yu CH; Wang T; Sun YE; Yao SL; Tian JH; Yin DY
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):90-2. PubMed ID: 16620664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non-Small Cell Lung Cancer.
    Ohno Y; Fujisawa Y; Sugihara N; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2017 Nov; 209(5):W253-W262. PubMed ID: 28929810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.